On Nov. 16, Pfizer Inc. announced a partnership with the University of California at San Francisco aimed at translating biotechnology discoveries into marketable drugs. It's the newest element of a multifaceted, R&D makeover that's designed to transform the New York-based pharmaceutical giant into a biotechnology powerhouse.